Comprehensive Study Guide to Glycogen Metabolism: Synthesis, Degradation, Regulation, and Clinical Pathology

Molecular Mechanisms of Glycogen Synthesis

  • Conversion of Glucose-6-Phosphate to Glucose-1-Phosphate

    • The initial step in glycogen synthesis involves the isomerization of Glucose-6-phosphate (Gluc-6-PGluc\text{-}6\text{-}P) to Glucose-1-phosphate (Gluc-1-PGluc\text{-}1\text{-}P).

    • This reaction is catalyzed by the enzyme phosphoglucomutase.

    • The chemical structures involved are:

      • Glucose-6-phosphate: A glucose ring with a phosphate group attached to the CH2CH_2 group at position 6.

      • Glucose-1-phosphate: A glucose ring with the phosphate group attached to the oxygen at position 1.

  • Activation of Glucose-1-Phosphate

    • To be added to a glycogen chain, Gluc-1-PGluc\text{-}1\text{-}P must be activated.

    • This process requires Uridine Triphosphate (UTP) and is catalyzed by the enzyme UDP-glucose pyrophosphorylase.

    • The reaction proceeds as follows:

      • Gluc-1-P+UTPUDP-glucose+PPiGluc\text{-}1\text{-}P + UTP \rightarrow UDP\text{-}glucose + PP_i

    • The byproduct, inorganic pyrophosphate (PPiPP_i), is immediately hydrolyzed into two inorganic phosphates (2Pi2\,P_i) by the enzyme inorganic pyrophosphatase. This hydrolysis renders the synthesis of UDP-glucose irreversible.

  • Glycogen Chain Extension and Branching

    • Two primary enzymes are responsible for the addition of glucose units to the glycogen molecule:

      1. Glycogen synthase: This enzyme creates α-1,4\alpha\text{-}1,4 linkages. It transfers a glucose residue from UDP-glucose to the non-reducing end of a glycogen core, releasing UDP.

      2. Amylo-\alpha(1,4 \rightarrow 1,6)-glucosyltransferase (Branching enzyme): This enzyme forms α-1,6\alpha\text{-}1,6 linkages. It removes a string of glucose residues from a chain and reattaches them via an α-1,6\alpha\text{-}1,6 bond to create a branch point.

    • The process of chain extension and branching allows the core to expand from multiple non-reducing ends simultaneously.

  • Energetics of Glycogen Synthesis

    • Starting from free glucose, the process consumes two high-energy phosphate bonds per glucose residue added:

      1. Hexokinase: Initial phosphorylation of glucose to Gluc-6-PGluc\text{-}6\text{-}P.

      2. UDP-glucose pyrophosphorylase: Utilization of UTP.

    • Total energy cost: 2ATP2\,ATP equivalents per residue.

Biochemistry of Glycogen Breakdown (Glycogenolysis)

  • The Phosphorolysis Process

    • Glycogen breakdown is an energy-efficient process that requires no initial ATP investment.

    • Glucose units are removed one at a time from the non-reducing ends of the glycogen polymer.

    • The process uses inorganic phosphate (PiP_i) and the enzyme glycogen phosphorylase.

    • The resulting product is glucose-1-phosphate (Gluc-1-P).

    • Constraint: Glycogen phosphorylase can only cleave α-1,4\alpha\text{-}1,4 glycosidic linkages.

  • Debranching Mechanism

    • Because phosphorylase cannot break α-1,6\alpha\text{-}1,6 bonds at branch points, a debranching enzyme is required.

    • This enzyme has two distinct activities:

      1. Transferase: Moves a block of three glucose residues from one outer branch to another, exposing the single glucose residue attached by an α-1,6\alpha\text{-}1,6 bond.

      2. \alpha-1,6-Glucosidase: Hydrolyzes the α-1,6\alpha\text{-}1,6 linkage, releasing a free glucose molecule.

  • Energetics of Glycogen Utilization

    • Aerobic conditions (Muscle): Conversion to Gluc-6-PGluc\text{-}6\text{-}P leads to Glycolysis and then the Citric Acid Cycle (CAC).

    • Anaerobic conditions (Muscle): Conversion to Gluc-6-PGluc\text{-}6\text{-}P leads to Glycolysis, resulting in the production of Lactate.

Allosteric and Covalent Regulation of Glycogen Phosphorylase

  • Structural Forms of Phosphorylase

    • Phosphorylase a: The phosphorylated form, which is typically active.

    • Phosphorylase b: The dephosphorylated form, which is typically inactive.

    • Both forms exist in an equilibrium between the R (Relaxed/Active) state and the T (Tense/Inactive) state.

  • Organ-Specific Allosteric Regulation

    • In the Liver: The primary role is maintaining blood glucose. In the liver, Phosphorylase a is regulated by glucose levels. When glucose binds to the enzyme, it promotes the transition from the active R state to the inactive T state.

    • In the Muscle: The primary role is providing energy for contraction. Phosphorylase b is regulated by the energy charge of the cell:

      • AMP: High levels of AMP (signaling low energy) bind to nucleotide-binding sites and promote the transition from the T state to the active R state.

      • ATP and Glucose-6-phosphate: High levels of these molecules (signaling high energy) inhibit the enzyme, favoring the T state.

  • The Role of Phosphorylase Kinase

    • Phosphorylase kinase is responsible for converting Phosphorylase b into Phosphorylase a via phosphorylation.

    • It is a complex enzyme (αβγδ\alpha\beta\gamma\delta) regulated by two main signals:

      1. Calcium Ions (Ca2+Ca^{2+}): Calcium binds to the δ\delta subunit (calmodulin). This occurs during nerve impulses and muscle contraction, providing partial activation.

      2. Phosphorylation: Protein Kinase A (PKA) phosphorylates the enzyme in response to hormones, leading to full activation.

Hormonal Control and Signal Transduction Pathways

  • Hormone Functions

    • Insulin: Promotes glycogen synthesis after a meal.

    • Glucagon (Liver): Promotes glycogen degradation to increase blood sugar levels during fasting.

    • Epinephrine (Muscle and Liver): Promotes glycogen degradation during exercise or "fight or flight" responses.

  • The Signal Cascade for Degradation

    • Binding of Glucagon or Epinephrine to a 7TM receptor activates a Trimeric G protein.

    • The G protein (α\alpha subunit) activates Adenylate cyclase, which converts ATP to Cyclic AMP (cAMP).

    • cAMP activates Protein Kinase A (PKA).

    • PKA performs a dual regulatory role:

      1. It phosphorylates and activates Phosphorylase kinase, which subsequently phosphorylates and activates Phosphorylase b to Phosphorylase a.

      2. It phosphorylates Glycogen synthase, converting it from the active 'a' form to the inactive 'b' form (Glycogen synthase kinase also participates in this inactivation).

  • Regulation After a Meal or at Rest

    • Glycogen synthesis must be stimulated while breakdown is inhibited.

    • Protein Phosphatase 1 (PP1) plays a central role by removing phosphate groups.

    • PP1 dephosphorylates:

      • Phosphorylase kinase (inactivating it).

      • Phosphorylase a (converting it to inactive Phosphorylase b).

      • Glycogen synthase b (converting it to active Glycogen synthase a).

  • Insulin Signaling Pathway

    • Insulin binds to its receptor, leading to the phosphorylation of Insulin Receptor Substrates (IRS).

    • This activates protein kinases that phosphorylate and inactivate Glycogen Synthase Kinase.

    • Inactivation of the kinase, combined with the action of PP1, shifts the equilibrium toward the active Glycogen synthase a.

Table 25.1: Clinical Correlates (Glycogen-Storage Diseases)

Type

Disease Name

Defective Enzyme

Organ Affected

Glycogen Status

Clinical Features

I

von Gierke disease

Glucose 6-phosphatase or transport system

Liver and kidney

Increased amount; normal structure

Massive liver enlargement; Failure to thrive; Severe hypoglycemia, ketosis, hyperuricemia, hyperlipemia.

II

Pompe disease

α-1,4-Glucosidase\alpha\text{-}1,4\text{-}Glucosidase (lysosomal)

All organs

Massive increase in amount; normal structure

Cardiorespiratory failure cause death, usually before age 2.

III

Cori disease

α-1,6-glucosidase\alpha\text{-}1,6\text{-}glucosidase (debranching enzyme)

Muscle and liver

Increased amount; short outer branches

Like type I, but milder course.

IV

Andersen disease

Branching enzyme (α-1,4α-1,6\alpha\text{-}1,4 \rightarrow \alpha\text{-}1,6)

Liver and spleen

Normal amount; very long outer branches

Progressive cirrhosis of the liver; Liver failure causes death, usually before age 2.

V

McArdle disease

Phosphorylase

Muscle

Moderately increased amount; normal structure

Limited ability to perform strenuous exercise due to painful muscle cramps. Otherwise normal.

VI

Hers disease

Phosphorylase

Liver

Increased amount

Like type I, but milder course.

VII

Tarui disease

Phosphofructokinase

Muscle

Increased amount; normal structure

Like type V.

VIII

--

Phosphorylase kinase

Liver

Increased amount; normal structure

Mild liver enlargement; Mild hypoglycemia.

  • Inheritance Notes:

    • Types I through VII are inherited as autosomal recessives.

    • Type VIII is sex-linked.